Bone marrow necrosis as complication of treatment with all-trans retinoic acid and arsenic trioxide: case report and implications for treatment

Ann Hematol. 2022 May;101(5):1133-1134. doi: 10.1007/s00277-021-04720-8. Epub 2021 Nov 8.

Authors

Carin L E Hazenberg¹, Arjan Diepstra², Michiel Santing³, Gerwin A Huls¹, Emanuele Ammatuna⁴

Affiliations

¹ Department of Hematology, University Medical Centre Groningen, Groningen, The Netherlands.
² Department of Pathology and Medical Biology, University Medical Centre Groningen, Groningen, The Netherlands.
³ Department of Radiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
⁴ Department of Hematology, University Medical Centre Groningen, Groningen, The Netherlands. [email protected].

PMID: 34750663
DOI: 10.1007/s00277-021-04720-8

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Arsenic Trioxide / adverse effects
Arsenicals* / therapeutic use
Bone Marrow
Humans
Leukemia, Promyelocytic, Acute* / drug therapy
Necrosis
Tretinoin / adverse effects

Substances

Arsenicals
Tretinoin
Arsenic Trioxide